U.S. market Open. Closes in 6 hours

JNJ | Johnson & Johnson Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for JNJ we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is moderate, Growth is very bad and Health is very weak.

Valuation (60%)

Company Industry
P/E Ratio (TTM) 26.60 47.53
PEG Ratio (TTM) -0.44 2.49
P/S Ratio (TTM) 4.42 8.63
P/B Ratio (TTM) 5.46 24.62
P/FCF Ratio (TTM) 28.10 -43.64
Price to 5YR AVG Earnings Ratio 20.10 58.85
Price to 5YR AVG FCF Ratio 20.92 88.41

Profitability (55%)

Company Industry
ROA (TTM) N/A 6.56%
ROE (TTM) 20.84% 31.22%
Net Profit Margin (TTM) 16.74% 13.37%
ROIC 5YR AVG 23.73% 20.64%

Growth (35%)

4QTR AVG 3YR AVG 5YR AVG
EPS -4.57% 8.42% 25.63%
Revenue 1.26% 5.52% 1.46%
Net Income -4.54% 8.38% 24.22%
Cash Flow -24.86% -3.16% -0.39%

Health (33%)

Company Industry
Current Ratio (TTM) N/A 1.11
Quick Ratio (TTM) N/A 0.88
D/E Ratio (TTM) N/A 3.19
Interest Coverage (TTM) 42.85 15.05
Piotroski F-Score 8 6
Altman Z-Score N/A 4.79
LTL to 5YR AVG FCF 1.40 4.05
Shares Outstanding Growth 5YR AVG -0.76% 1.14%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙